지원사업
학술연구/단체지원/교육 등 연구자 활동을 지속하도록 DBpia가 지원하고 있어요.
커뮤니티
연구자들이 자신의 연구와 전문성을 널리 알리고, 새로운 협력의 기회를 만들 수 있는 네트워킹 공간이에요.
이용수
초록· 키워드
오류제보하기
This study was carried out to identify the important risk factors for reduced bone mass of postmenopausal RA patients and to develop discriminant function which can classify postmenopausal RA patients with either reduced or normal bone mass.
Through the literature review, individual characteristics such as age, body weight, height. age of menarche, duration of menopause, gravity, parity, and breast feeding period and factors of life style such as milk consumption exercise habit. alcohol intake, cigarette smoking, coffee consumption, disease activity, corticosteroid therapy were identified as influencing factors of reduced bone mass in RA patients
Sixty eight postmenopausal women with rheumatoid arthritis aged between 42 and 76 were selected among those who checked bone mineral density in lumbar spine and femur from October. 1998 to April. 1999 at Dong-a university hospital in Pusan.
Assessment of disease activity, duration of disease and corticosteroid therapy were made by the same rheumatologist and included Ritchie articular index, erythrocyte sedimentation rate, and C-reactive measuring bone protein on mineral density. Cumulative steroid dosage was calculated from the daily dosage multiplied by the number of days received. The information of other risk factor including health assessment score, individual characteristics and life style factors were collected by questionnaire. Bone mineral density(BMD) was measured using DXA at lumbar spine and femoral Ward's triangle. Discriminant function (regression equation) was developed for estimating the likelihood of the presence or absence of reduced bone mass. The results are as follows:
Among the subjects, thirteen(l9.1%) exhibited osteoporosis in lumbar spine and twenty four(35.3%) exhibited osteoporosis in femoral Ward's triangle.
For lumbar spine, the variables significant were age, body weight, health assessment score, while for femoral Ward's triangle, age, body weight, duration of disease. But disease activity and corticosteroid therapy were not signigicant to distinguish reduced bone mass from normal bone mass.
When the discriminant function was evaluated by comparing the observed outcome with predicted outcome, the discriminant function correctly classified 85.4% of patients with reduce bone mass and 63.0% of patients with normal bone mass in the lumbar spine and 100% of patients with reduced bone mass and 9.1% of patients with normal bone mass in the femoral Ward's triangle.
In summary, we found that osteoporosis in postmenopausal women with RA is more evident at the femur than the lumbar spine. Also the important discriminant factors of reduced bone mass postmenopausal women with RA were age, body weight, duration of disease and health disability.
In nursing situation, the efforts to improve of functional capacity of postmenopausal women with rheumatoid arthritis should be considered to prevent osteoporosis and fractures.
Also we recommend those postmenopausal women with RA who are classified as a group of the reduced bone mass in the discriminant function should examine the bone mineral density to further examine the usefulness of this discriminant function.
Through the literature review, individual characteristics such as age, body weight, height. age of menarche, duration of menopause, gravity, parity, and breast feeding period and factors of life style such as milk consumption exercise habit. alcohol intake, cigarette smoking, coffee consumption, disease activity, corticosteroid therapy were identified as influencing factors of reduced bone mass in RA patients
Sixty eight postmenopausal women with rheumatoid arthritis aged between 42 and 76 were selected among those who checked bone mineral density in lumbar spine and femur from October. 1998 to April. 1999 at Dong-a university hospital in Pusan.
Assessment of disease activity, duration of disease and corticosteroid therapy were made by the same rheumatologist and included Ritchie articular index, erythrocyte sedimentation rate, and C-reactive measuring bone protein on mineral density. Cumulative steroid dosage was calculated from the daily dosage multiplied by the number of days received. The information of other risk factor including health assessment score, individual characteristics and life style factors were collected by questionnaire. Bone mineral density(BMD) was measured using DXA at lumbar spine and femoral Ward's triangle. Discriminant function (regression equation) was developed for estimating the likelihood of the presence or absence of reduced bone mass. The results are as follows:
Among the subjects, thirteen(l9.1%) exhibited osteoporosis in lumbar spine and twenty four(35.3%) exhibited osteoporosis in femoral Ward's triangle.
For lumbar spine, the variables significant were age, body weight, health assessment score, while for femoral Ward's triangle, age, body weight, duration of disease. But disease activity and corticosteroid therapy were not signigicant to distinguish reduced bone mass from normal bone mass.
When the discriminant function was evaluated by comparing the observed outcome with predicted outcome, the discriminant function correctly classified 85.4% of patients with reduce bone mass and 63.0% of patients with normal bone mass in the lumbar spine and 100% of patients with reduced bone mass and 9.1% of patients with normal bone mass in the femoral Ward's triangle.
In summary, we found that osteoporosis in postmenopausal women with RA is more evident at the femur than the lumbar spine. Also the important discriminant factors of reduced bone mass postmenopausal women with RA were age, body weight, duration of disease and health disability.
In nursing situation, the efforts to improve of functional capacity of postmenopausal women with rheumatoid arthritis should be considered to prevent osteoporosis and fractures.
Also we recommend those postmenopausal women with RA who are classified as a group of the reduced bone mass in the discriminant function should examine the bone mineral density to further examine the usefulness of this discriminant function.
목차
1. 서론
2. 문헌고찰
3. 연구방법
4. 연구결과
5. 논의
6. 결론 및 제언
참고문헌
Abstract
참고문헌 (0)
참고문헌 신청함께 읽어보면 좋을 논문
논문 유사도에 따라 DBpia 가 추천하는 논문입니다. 함께 보면 좋을 연관 논문을 확인해보세요!
-
폐경후에 골밀도의 관련인자 분석
대한물리치료학회지(JKPT)
2001 .01
-
소아의 골밀도에 관한 연구
대한한방소아과학회지
2005 .01
-
폐경 여성의 생식 관련 요인과 생활양식이 골밀도에 미치는 영향
Women's Health Nursing
2008 .01
-
한국 폐경 여성의 골다공증 위험 인자에 관한 연구
한국건강관리협회지
2004 .01
-
골다공증의 진단
Hip and Pelvis
2009 .01
-
골다공증 발생요인에 따른 골대사 생화학적 지표의 변동 고찰
대한물리치료학회지(JKPT)
2002 .01
-
이중에너지 방사선 흡수계측법(DEXA)을 이용한 성인들의 체구성과 골밀도 분석
대한물리치료학회지(JKPT)
2003 .01
-
일부 여성의 요통과 골밀도에 관한 분석
대한물리치료사학회지
2001 .01
-
Increased Bone Mineral Density after Abstinence in Male Patients with Alcohol Dependence
Clinical Psychopharmacology and Neuroscience
2018 .01
-
The Early Onset of Disease May Be a Risk Factor for Decreased Bone Mineral Density in Patients with Inflammatory Bowel Disease
Clinical Endoscopy
2013 .01
-
폐경 후 연령대별 골밀도 영향 요인
보건의료산업학회지
2017 .01
-
성인남녀 480명에서의 골밀도와 비만의 상관관계에 관한 임상적 연구
대한침구의학회지
1998 .01
-
폐경전 무월경 여성에 있어서 골밀도 측정에 관한 연구
대한불임학회잡지
1992 .01
-
건강진단상 여성골밀도 측정의 통계학적 관찰
보험의학회지
1996 .01
-
젊은 여성과 대퇴경부 저골밀도 폐경기 여성의 신체조성과 골밀도의 상관관계 연구
대한고유수용성신경근촉진법학회지
2011 .01
-
Bone modeling, remodeling, and skeletal health in children and adolescents: mineral accrual, assessment and treatment
Annals of Pediatirc Endocrinology & Metabolism
2017 .01
-
우리나라 성인남녀의 골밀도 관련요인 : 국민건강영양조사 제 5기 1, 2차 년도(2010년, 2011년)
농촌의학·지역보건
2014 .12
-
젊은 성인여성에서 낮은 골밀도의 위험요인과 평가
Korean Journal of Family Medicine
2009 .01
이 논문의 저자 정보
이 논문과 함께 이용한 논문
한국인의 심뇌혈관질환 발생 위험요인
지선하
성인간호학회 학술대회
2010
.05
흉통을 호소하는 여성 환자에서 허리둘레와 관상동맥질환 위험인자간의 관계에 관한 조사연구
윤경순
,
조숙희
기본간호학회지
2013
.08
심뇌혈관질환 고위험군을 위한 지역사회 단계별 교육프로그램 개발 및 효과 평가
이혜진
,
이중정
,
황태윤
외 1명
농촌의학·지역보건
2012
.09
일 지역 남성 운전직 근로자들의 심뇌혈관질환 발병위험도, 예방 관련 지식, 변화단계 및 건강행위
김은영
,
황선영
성인간호학회지
2011
.08
간호사와 간호조무사가 지각하는 방사선사 인식도
신성규
한국콘텐츠학회논문지
2011
.08
최근 본 자료
댓글(0)
0
UCI(KEPA) : I410-ECN-0101-2009-513-014229355